哈萨克族人β3受体和过氧化物酶增殖体激活受体γ2基因复合变异与代谢综合征的关系

目的检测新疆哈萨克族人群中β3受体基因Trp64Arg多态和过氧化物酶增殖体激活受体γ2（peroxisome proliferators-activated receptorγ2，PPARγ2）基因Pro12Ala多态联合变异与单纯腹型肥胖和代谢综合征的关系。方法应用聚合酶链反应和限制性片断长度多态性技术检测代谢综合征159例，单纯腹型肥胖78例和正常人基因型106例，同时测定相关的生化指标，并进行统计学分析。结果Trp64Arg多态和Pro12Ala多态及两基因的联合变异的基因型和等位基因频率在3组问差异无统计学意义。结论β3受体Trp64Arg多态和PPARγ2的Pro12Ala多态及两基因的联合变异与哈萨克族人群腹型肥胖及代谢综合征无明显关联。     

吸烟和β2-肾上腺素能受体基因Gln27Glu变异与新疆哈萨克族肥胖性高血压的关系

目的:探讨新疆哈萨克族体质指数(BMI)增高、高血压及血脂异常与β2-肾上腺素能受体(ADRB2)基因变异及非遗传因素的关系。方法:选取新疆和丰县牧区30～70岁哈萨克牧民671例(男283例,女388例),检测血清TC,TG,HDL,LDL。用PCR-限制性酶切片段多态性技术确定ADRB2基因Gln27Glu和Thr164Ile位点基因型。结果:①ADRB2基因Thr164Ile位点仅检测到5例Thr/Ile杂合子,约占1%,Ile/Ile基因型未检测到。②校正性别和年龄后,Gln27Glu和Thr164Ile位点各自不同基因型间BMI、血压和血脂平均水平比较差异均无统计学意义。③多元Logistic回归分析提示:TG、舒张压(DBP)是BMI增高的风险因素,与(Glu27Glu+吸烟)相比,(Gln27Glu+不吸烟)引起BMI增高风险增加1.69倍(95%CI:0.99～2.88),而(Gln27Gln+不吸烟)增高2.71倍(95%CI:1.49～4.92)。④多元方差分析提示,年龄、吸烟和饮酒对BMI、血压和TG的影响差异有统计学意义,而Gln27Glu位点仅对BMI有影响。⑤与体重正常者相比,超重者DBP增高的风险增加1.47倍(95%CI:1.03～2.09),肥胖者增加2.64倍(95%CI:1.69～4.11)。超重和肥胖者高TG的风险分别增加2.05倍(95%CI:1.27～3.31)和3.49倍(95%CI:2.06～5.92)。结论:新疆哈萨克族人群BMI和DBP,TG互为风险因素,且可能受到年龄、ADRB基因Glu27Glu变异和吸烟交互作用以及饮酒的影响。     

尿酸与腹型肥胖及代谢综合征相关性研究

 目的 探讨血清尿酸(UA)水平的变化与腹型肥胖及代谢综合征(MS)的相关性。方法 875例40~65岁杭州社区居民进入研究,其中男350例,女525例。对所有研究对象均进行问卷调查、体检和血清学检查,并进行腹部MRI扫描,测量腹内脂肪面积和皮下脂肪面积,分析UA水平与腹型肥胖和MS的相关性,并确定UA作为MS诊断的参考指标的最佳界值。结果 该人群中随着 UA 水平增加,腹型肥胖(男性OR=4.35,95%CI 1.91~9.90;女性OR=5.44,95%CI 2.41~12.31) 和MS(男性OR=4.47,95%CI 2.08~9.62;女性OR=11.62,95%CI 3.43~39.37)风险增加。多项logistic 回归分析显示,UA 是TG升高(男性OR=2.23,95%CI 1.02~4.87;女性OR=3.04,95%CI 1.49~6.23)、女性腹型肥胖(OR=3.23,95%CI 1.32~7.91)和血压升高(OR=2.35,95%CI 1.37~4.05)的独立危险因素。在女性中,根据腹内脂肪面积建立多元线性回归模型,UA的最佳切点为244.0 μmol/L,而通过受试者ROC曲线获得MS诊断的最佳界值为258.8 μmol/L。结论 在我国中年人群中,UA与腹型肥胖和MS密切相关。UA水平升高是女性腹型肥胖和MS的独立危险因素。     

IL-13基因和β2-AR基因多态性与哮喘的关系

选择48例支气管哮喘患者为哮喘组,48例健康者为对照组,采用聚合酶链反应一限制性片段长度多态性检测白介素13(IL-13)基因Intron3 1923位点C/T和β2肾上腺素能受体(β2-AR)基因R16G 单核苷酸多态性(SNP).发现哮喘组IL-13 Intron3 1923 TT、TC基因型频率及β2-AR R16G AA基因型频率分布均明显高于对照组;哮喘组中IL-13 Intron3 1923 CC型或β2-AR R16G AA型有明显相关性.提示IL-13 Intron3 1923非CC型和β2-AR R16G AA型与哮喘的发生有密切关系并起协同作用.     

CAPN-10基因与新疆维吾尔族及哈萨克族人群2型糖尿病的相关性

对新疆维吾尔族和哈萨克旅人群中正常糖耐量、2型糖尿病和糖耐量减低者的研究显示，Calpain-10基因的第43和第19位点单核苷酸多态性(SNP-43和19)与T2DM的发生相关，与哈萨克族人群的血脂异常和胰岛素抵抗相关。     

新疆哈族人群体质指数及血脂水平与β2-AR基因+491C/T多态性的关系

目的研究新疆哈萨克族人群体质指数(BMI)、血脂水平与β2-肾上腺素能受体 491C/T多态性的关系.方法以人群为基础的病例-对照研究,针对528例30～60岁哈萨克族人,测量其身高、体重,在此基础上计算BMI,按照WHO的标准将其划分为正常(18.5≤BMI＜25)、超重(25≤BMI＜30)及肥胖(BMI≥30)3组,并采集其血液标本,测定TC、TG、HDL-C,计算LDL-C值,同时采用饱和酚/氯仿法提取外周血白细胞基因组DNA,应用PCR-RFLP技术检测β2-肾上腺素能受体 491C/T基因型及等位基因频率;采用方差分析、t检验、Fisher's精确概率检验、Logistic回归等统计学分析方法,观察不同BMI人群血脂水平的变化、不同基因型人群BMI和血脂水平差异、β2-肾上腺素能受体 491C/T基因型及等位基因频率的分布和TG、TC、BMI与β2-AR基因 491C/T多态性的关系.结果正常、超重、肥胖3组间血清TC、TG的水平随BMI增加而增高(均P＜0.01).正常组β2-肾上腺素能受体 491C/T基因型频率分别是CC 98.91%、CT 1.09%,超重加肥胖组为CC 98.8%、CT 1.2%;正常组等位基因频率分别为C 99.45%、T 0.55%,超重加肥胖组C 99.4%、T 0.60%,分布的差异均无统计学意义.各基因型间BMI、TC、TG差异无统计学意义.结论β2-AR基因 491位点C/T多态性可能不是新疆哈萨克族人群BMI、TG、TC异常的易感因素,而TC、TG水平增高是该人群超重、肥胖的危险因素.     

社区人群腹型肥胖与高血压关系调查

目的探讨伴有腰围/身高比超标的腹型肥胖与高血压的相关性及危险程度。方法采用整群抽样方法,对542名年龄35岁以上社区居民进行问卷调查、现场体检和实验室检查。结果 (1)年龄、体重指数(BMI)、腰围(WC)与高血压患病率相关。(2)WC与高血压患病率的相关性高于BMI。(3)在腹型肥胖的高血压患者中WC与腰围/身高比(WHtR)的关系最密切。结论肥胖是高血压患病的主要危险因素之一,腹型肥胖者患高血压的比例更高,WC和WHtR均可作为评估腹型肥胖的指标,控制体重减少腹型肥胖对预防高血压具有重要的意义。     

腹型肥胖患者体脂分布与代谢综合征及冠状动脉病变的关系

目的 探讨腹型肥胖患者各部位脂肪分布与代谢综合征（MS）和冠状动脉病变（CAD）的关系。方法 57例腹型肥胖患者,采用GE64层螺旋CT评估腹部、心脏及冠脉周围脂肪分布情况,超声评估肾脏周围脂肪分布情况,同时测量血生化指标、体质量指数和腰臀比等。结果 ①MS组VAT、肾短轴脂肪面积及Gessini积分显著高于单纯肥胖组〔分别为(2290±601) cc vs.(3024±792) cc;(13.4±1.1) mm2 vs.(18.8±2.2) mm2;(20±3) vs.(46±6);P<0.05,P<0.01〕;多因素Logistic回归分析显示VAT是MS的独立危险因素（OR=1.002,95%CI 1.000-1.003,P<0.05）;②Gessini评分>80分组WHR、MS异常代谢组分个数、糖尿病比例、CYS-C、EAT、冠脉周围脂肪厚度均显著高于Gessini评分40~80分组及Gessini评分<40分组〔分别为(1.10±0.01) vs.(0.96±0.01)、(0.96±0.01);(4.38±0.38) vs.(3.35±0.27)、(2.71±0.27);71% vs. 17%、6%;(1.33±0.21) mg/L vs.(1.03±0.07) mg/L、(0.86±0.04) mg/L;(217±58) cc vs.(201±18) cc、(129±18) cc;(17.0±1.2) mm vs.(14.3±0.6) mm、(10.4±0.6) mm;P<0.05,P<0.01〕。多因素逐步回归分析显示,MS异常代谢组分个数、CYS-C、冠脉周围脂肪厚度是影响冠脉病变程度的危险因素。结论 肥胖患者体内不同部位的脂肪沉积对其代谢、心血管疾病的作用具有差异性;在明显肥胖患者中,心脏及冠脉周围脂肪分布可能是更重要的心血管危险因子。     

不同肥胖指标及血细胞参数与新疆哈萨克族人群高血压易感性的关系

目的探讨不同肥胖指标及血细胞参数与新疆哈萨克族(哈族)人群高血压易感性的关系。方法采用整群随机抽样的方法对新疆南山牧区"三镇一乡"的哈族牧民或半农半牧民3 042人进行肥胖指标中体重指数(BMI)、腰围(WC)、腰臀比(WHR)和腰围身高比(WHt R)测量及血细胞参数检查,其中高血压患者(高血压组)1 487例,血压正常者(对照组)1 555例,采用Pearson相关性分析不同肥胖指标及血细胞参数变化与高血压的相关性,非条件Logistic回归模型分析不同肥胖指标及血细胞参数变化对高血压的影响。结果高血压组和血压正常组中,除身高、血小板计数外,其余变量超重/肥胖者的水平与BMI正常者比较差异均有统计学意义(P0.05)。新疆哈族居民的肥胖指标(BMI、WC、WHR、WHt R)、红细胞参数[血细胞比容(HCT)、平均红细胞体积(MCV)]及血小板参数[血小板压积(PCT)、平均血小板体积(MPV)]与收缩压、舒张压均有相关性(P0.05);逐步多因素非条件Logistic回归结果显示,BMI、WC、WHR、WHt R,HCT及PCT、MPV均为患高血压的危险因素(P0.05)。结论监测新疆哈族居民的肥胖指标及血细胞参数的变化对控制血压及预防心血管并发症均具有重要意义。     

青岛市湛山社区人群代谢综合征与肥胖的关系

调查青岛市湛山社区20～74岁长住居民代谢综合征及其各组分与体重指数(BMI)的关系。结果显示随着BMI的增加,代谢综合征及其各组分的患病率及相对危险性增加,约1/3的超重和肥胖个体患有代谢综合征。     

2型糖尿病家系一级亲人群代谢综合征患病情况及与肥胖相关指标的关系

Objective To compare the differences of metabolic syndrome (MS) prevalence by using four working definitions and their relationship with obesity-related indicators in first-degree relatives of type 2 diabetes mellitus pedigrees. Methods Totally, 2 372 first-degree relatives from 715 type 2 diabetic pedigrees were selected in this study. Complete laboratory data, including blood pressure, lipid profile and plasma glucose, were collected. The prevalence rates of MS and obesity of four definitions, as defined by National Cholesterol Education Program Adult Treatment Panel Ⅲ (ATPⅢ) in 2005, International Diabetes Federation (IDF) in 2005,Chinese Diabetes Society (CDS) in 2004 aml Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults (JCDCG) in 2007,were analyzed. Results (1)The prevalence rates of MS were 45.40% ,38.74% ,25.08% and 39.29% aecording to four definitions respectively. The prevalence rates of MS were higher in females than in males by using ATPⅢ and IDF definitions (both P<0. 01). (2)The common comhinations of metabolic abnormality was dyslipidemia, hypertension, obesity and hyperglycemia by using four definitions,except in females by using CDS definition. (3)The prevalence rates of obesity were 58.18% ,58.18% ,33.90% and 42.96% acconling to the four definitions respectively. The prevalence rates of MS in obese subjects were 66.59% ,66.59% ,54.85% and 68.99% according to four definitions respectively. (4) Applying the cutoff point for abdominal obesity according to ATPⅢ, IDF and JCDCG definitions, the prevalence rates of abdominal obesity in subjects with body mass index (BMI) <25 kg/m2 were respectively 28.58% and 16.78%, being higher in females than in males(38.90% vs 15.02% ,21.01% vs 11.22% ,both P<0. 01). Conclusion (1)There is significant familial aggregation of MS and obesity,and the first-degree relatives of type 2 diabetic patients are high risk populations. (2) Waist circumference rather than BMI taken as a discriminating component of obesity in MS seems to be clinically more helpful to the early identification and prevention of MS.     

2型糖尿病家系一级亲人群代谢综合征患病情况及与肥胖相关指标的关系

Objective To compare the differences of metabolic syndrome (MS) prevalence by using four working definitions and their relationship with obesity-related indicators in first-degree relatives of type 2 diabetes mellitus pedigrees. Methods Totally, 2 372 first-degree relatives from 715 type 2 diabetic pedigrees were selected in this study. Complete laboratory data, including blood pressure, lipid profile and plasma glucose, were collected. The prevalence rates of MS and obesity of four definitions, as defined by National Cholesterol Education Program Adult Treatment Panel Ⅲ (ATPⅢ) in 2005, International Diabetes Federation (IDF) in 2005,Chinese Diabetes Society (CDS) in 2004 aml Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults (JCDCG) in 2007,were analyzed. Results (1)The prevalence rates of MS were 45.40% ,38.74% ,25.08% and 39.29% aecording to four definitions respectively. The prevalence rates of MS were higher in females than in males by using ATPⅢ and IDF definitions (both P<0. 01). (2)The common comhinations of metabolic abnormality was dyslipidemia, hypertension, obesity and hyperglycemia by using four definitions,except in females by using CDS definition. (3)The prevalence rates of obesity were 58.18% ,58.18% ,33.90% and 42.96% acconling to the four definitions respectively. The prevalence rates of MS in obese subjects were 66.59% ,66.59% ,54.85% and 68.99% according to four definitions respectively. (4) Applying the cutoff point for abdominal obesity according to ATPⅢ, IDF and JCDCG definitions, the prevalence rates of abdominal obesity in subjects with body mass index (BMI) <25 kg/m2 were respectively 28.58% and 16.78%, being higher in females than in males(38.90% vs 15.02% ,21.01% vs 11.22% ,both P<0. 01). Conclusion (1)There is significant familial aggregation of MS and obesity,and the first-degree relatives of type 2 diabetic patients are high risk populations. (2) Waist circumference rather than BMI taken as a discriminating component of obesity in MS seems to be clinically more helpful to the early identification and prevention of MS.     

2型糖尿病家系一级亲人群代谢综合征患病情况及与肥胖相关指标的关系

Objective To compare the differences of metabolic syndrome (MS) prevalence by using four working definitions and their relationship with obesity-related indicators in first-degree relatives of type 2 diabetes mellitus pedigrees. Methods Totally, 2 372 first-degree relatives from 715 type 2 diabetic pedigrees were selected in this study. Complete laboratory data, including blood pressure, lipid profile and plasma glucose, were collected. The prevalence rates of MS and obesity of four definitions, as defined by National Cholesterol Education Program Adult Treatment Panel Ⅲ (ATPⅢ) in 2005, International Diabetes Federation (IDF) in 2005,Chinese Diabetes Society (CDS) in 2004 aml Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults (JCDCG) in 2007,were analyzed. Results (1)The prevalence rates of MS were 45.40% ,38.74% ,25.08% and 39.29% aecording to four definitions respectively. The prevalence rates of MS were higher in females than in males by using ATPⅢ and IDF definitions (both P<0. 01). (2)The common comhinations of metabolic abnormality was dyslipidemia, hypertension, obesity and hyperglycemia by using four definitions,except in females by using CDS definition. (3)The prevalence rates of obesity were 58.18% ,58.18% ,33.90% and 42.96% acconling to the four definitions respectively. The prevalence rates of MS in obese subjects were 66.59% ,66.59% ,54.85% and 68.99% according to four definitions respectively. (4) Applying the cutoff point for abdominal obesity according to ATPⅢ, IDF and JCDCG definitions, the prevalence rates of abdominal obesity in subjects with body mass index (BMI) <25 kg/m2 were respectively 28.58% and 16.78%, being higher in females than in males(38.90% vs 15.02% ,21.01% vs 11.22% ,both P<0. 01). Conclusion (1)There is significant familial aggregation of MS and obesity,and the first-degree relatives of type 2 diabetic patients are high risk populations. (2) Waist circumference rather than BMI taken as a discriminating component of obesity in MS seems to be clinically more helpful to the early identification and prevention of MS.     

2型糖尿病家系一级亲人群代谢综合征患病情况及与肥胖相关指标的关系

Objective To compare the differences of metabolic syndrome (MS) prevalence by using four working definitions and their relationship with obesity-related indicators in first-degree relatives of type 2 diabetes mellitus pedigrees. Methods Totally, 2 372 first-degree relatives from 715 type 2 diabetic pedigrees were selected in this study. Complete laboratory data, including blood pressure, lipid profile and plasma glucose, were collected. The prevalence rates of MS and obesity of four definitions, as defined by National Cholesterol Education Program Adult Treatment Panel Ⅲ (ATPⅢ) in 2005, International Diabetes Federation (IDF) in 2005,Chinese Diabetes Society (CDS) in 2004 aml Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults (JCDCG) in 2007,were analyzed. Results (1)The prevalence rates of MS were 45.40% ,38.74% ,25.08% and 39.29% aecording to four definitions respectively. The prevalence rates of MS were higher in females than in males by using ATPⅢ and IDF definitions (both P<0. 01). (2)The common comhinations of metabolic abnormality was dyslipidemia, hypertension, obesity and hyperglycemia by using four definitions,except in females by using CDS definition. (3)The prevalence rates of obesity were 58.18% ,58.18% ,33.90% and 42.96% acconling to the four definitions respectively. The prevalence rates of MS in obese subjects were 66.59% ,66.59% ,54.85% and 68.99% according to four definitions respectively. (4) Applying the cutoff point for abdominal obesity according to ATPⅢ, IDF and JCDCG definitions, the prevalence rates of abdominal obesity in subjects with body mass index (BMI) <25 kg/m2 were respectively 28.58% and 16.78%, being higher in females than in males(38.90% vs 15.02% ,21.01% vs 11.22% ,both P<0. 01). Conclusion (1)There is significant familial aggregation of MS and obesity,and the first-degree relatives of type 2 diabetic patients are high risk populations. (2) Waist circumference rather than BMI taken as a discriminating component of obesity in MS seems to be clinically more helpful to the early identification and prevention of MS.     

2型糖尿病家系一级亲人群代谢综合征患病情况及与肥胖相关指标的关系

Objective To compare the differences of metabolic syndrome (MS) prevalence by using four working definitions and their relationship with obesity-related indicators in first-degree relatives of type 2 diabetes mellitus pedigrees. Methods Totally, 2 372 first-degree relatives from 715 type 2 diabetic pedigrees were selected in this study. Complete laboratory data, including blood pressure, lipid profile and plasma glucose, were collected. The prevalence rates of MS and obesity of four definitions, as defined by National Cholesterol Education Program Adult Treatment Panel Ⅲ (ATPⅢ) in 2005, International Diabetes Federation (IDF) in 2005,Chinese Diabetes Society (CDS) in 2004 aml Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults (JCDCG) in 2007,were analyzed. Results (1)The prevalence rates of MS were 45.40% ,38.74% ,25.08% and 39.29% aecording to four definitions respectively. The prevalence rates of MS were higher in females than in males by using ATPⅢ and IDF definitions (both P<0. 01). (2)The common comhinations of metabolic abnormality was dyslipidemia, hypertension, obesity and hyperglycemia by using four definitions,except in females by using CDS definition. (3)The prevalence rates of obesity were 58.18% ,58.18% ,33.90% and 42.96% acconling to the four definitions respectively. The prevalence rates of MS in obese subjects were 66.59% ,66.59% ,54.85% and 68.99% according to four definitions respectively. (4) Applying the cutoff point for abdominal obesity according to ATPⅢ, IDF and JCDCG definitions, the prevalence rates of abdominal obesity in subjects with body mass index (BMI) <25 kg/m2 were respectively 28.58% and 16.78%, being higher in females than in males(38.90% vs 15.02% ,21.01% vs 11.22% ,both P<0. 01). Conclusion (1)There is significant familial aggregation of MS and obesity,and the first-degree relatives of type 2 diabetic patients are high risk populations. (2) Waist circumference rather than BMI taken as a discriminating component of obesity in MS seems to be clinically more helpful to the early identification and prevention of MS.     

2型糖尿病家系一级亲人群代谢综合征患病情况及与肥胖相关指标的关系

Objective To compare the differences of metabolic syndrome (MS) prevalence by using four working definitions and their relationship with obesity-related indicators in first-degree relatives of type 2 diabetes mellitus pedigrees. Methods Totally, 2 372 first-degree relatives from 715 type 2 diabetic pedigrees were selected in this study. Complete laboratory data, including blood pressure, lipid profile and plasma glucose, were collected. The prevalence rates of MS and obesity of four definitions, as defined by National Cholesterol Education Program Adult Treatment Panel Ⅲ (ATPⅢ) in 2005, International Diabetes Federation (IDF) in 2005,Chinese Diabetes Society (CDS) in 2004 aml Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults (JCDCG) in 2007,were analyzed. Results (1)The prevalence rates of MS were 45.40% ,38.74% ,25.08% and 39.29% aecording to four definitions respectively. The prevalence rates of MS were higher in females than in males by using ATPⅢ and IDF definitions (both P<0. 01). (2)The common comhinations of metabolic abnormality was dyslipidemia, hypertension, obesity and hyperglycemia by using four definitions,except in females by using CDS definition. (3)The prevalence rates of obesity were 58.18% ,58.18% ,33.90% and 42.96% acconling to the four definitions respectively. The prevalence rates of MS in obese subjects were 66.59% ,66.59% ,54.85% and 68.99% according to four definitions respectively. (4) Applying the cutoff point for abdominal obesity according to ATPⅢ, IDF and JCDCG definitions, the prevalence rates of abdominal obesity in subjects with body mass index (BMI) <25 kg/m2 were respectively 28.58% and 16.78%, being higher in females than in males(38.90% vs 15.02% ,21.01% vs 11.22% ,both P<0. 01). Conclusion (1)There is significant familial aggregation of MS and obesity,and the first-degree relatives of type 2 diabetic patients are high risk populations. (2) Waist circumference rather than BMI taken as a discriminating component of obesity in MS seems to be clinically more helpful to the early identification and prevention of MS.     

2型糖尿病家系一级亲人群代谢综合征患病情况及与肥胖相关指标的关系

Objective To compare the differences of metabolic syndrome (MS) prevalence by using four working definitions and their relationship with obesity-related indicators in first-degree relatives of type 2 diabetes mellitus pedigrees. Methods Totally, 2 372 first-degree relatives from 715 type 2 diabetic pedigrees were selected in this study. Complete laboratory data, including blood pressure, lipid profile and plasma glucose, were collected. The prevalence rates of MS and obesity of four definitions, as defined by National Cholesterol Education Program Adult Treatment Panel Ⅲ (ATPⅢ) in 2005, International Diabetes Federation (IDF) in 2005,Chinese Diabetes Society (CDS) in 2004 aml Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults (JCDCG) in 2007,were analyzed. Results (1)The prevalence rates of MS were 45.40% ,38.74% ,25.08% and 39.29% aecording to four definitions respectively. The prevalence rates of MS were higher in females than in males by using ATPⅢ and IDF definitions (both P<0. 01). (2)The common comhinations of metabolic abnormality was dyslipidemia, hypertension, obesity and hyperglycemia by using four definitions,except in females by using CDS definition. (3)The prevalence rates of obesity were 58.18% ,58.18% ,33.90% and 42.96% acconling to the four definitions respectively. The prevalence rates of MS in obese subjects were 66.59% ,66.59% ,54.85% and 68.99% according to four definitions respectively. (4) Applying the cutoff point for abdominal obesity according to ATPⅢ, IDF and JCDCG definitions, the prevalence rates of abdominal obesity in subjects with body mass index (BMI) <25 kg/m2 were respectively 28.58% and 16.78%, being higher in females than in males(38.90% vs 15.02% ,21.01% vs 11.22% ,both P<0. 01). Conclusion (1)There is significant familial aggregation of MS and obesity,and the first-degree relatives of type 2 diabetic patients are high risk populations. (2) Waist circumference rather than BMI taken as a discriminating component of obesity in MS seems to be clinically more helpful to the early identification and prevention of MS.     

2型糖尿病家系一级亲人群代谢综合征患病情况及与肥胖相关指标的关系

Objective To compare the differences of metabolic syndrome (MS) prevalence by using four working definitions and their relationship with obesity-related indicators in first-degree relatives of type 2 diabetes mellitus pedigrees. Methods Totally, 2 372 first-degree relatives from 715 type 2 diabetic pedigrees were selected in this study. Complete laboratory data, including blood pressure, lipid profile and plasma glucose, were collected. The prevalence rates of MS and obesity of four definitions, as defined by National Cholesterol Education Program Adult Treatment Panel Ⅲ (ATPⅢ) in 2005, International Diabetes Federation (IDF) in 2005,Chinese Diabetes Society (CDS) in 2004 aml Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults (JCDCG) in 2007,were analyzed. Results (1)The prevalence rates of MS were 45.40% ,38.74% ,25.08% and 39.29% aecording to four definitions respectively. The prevalence rates of MS were higher in females than in males by using ATPⅢ and IDF definitions (both P<0. 01). (2)The common comhinations of metabolic abnormality was dyslipidemia, hypertension, obesity and hyperglycemia by using four definitions,except in females by using CDS definition. (3)The prevalence rates of obesity were 58.18% ,58.18% ,33.90% and 42.96% acconling to the four definitions respectively. The prevalence rates of MS in obese subjects were 66.59% ,66.59% ,54.85% and 68.99% according to four definitions respectively. (4) Applying the cutoff point for abdominal obesity according to ATPⅢ, IDF and JCDCG definitions, the prevalence rates of abdominal obesity in subjects with body mass index (BMI) <25 kg/m2 were respectively 28.58% and 16.78%, being higher in females than in males(38.90% vs 15.02% ,21.01% vs 11.22% ,both P<0. 01). Conclusion (1)There is significant familial aggregation of MS and obesity,and the first-degree relatives of type 2 diabetic patients are high risk populations. (2) Waist circumference rather than BMI taken as a discriminating component of obesity in MS seems to be clinically more helpful to the early identification and prevention of MS.     

2型糖尿病家系一级亲人群代谢综合征患病情况及与肥胖相关指标的关系

Objective To compare the differences of metabolic syndrome (MS) prevalence by using four working definitions and their relationship with obesity-related indicators in first-degree relatives of type 2 diabetes mellitus pedigrees. Methods Totally, 2 372 first-degree relatives from 715 type 2 diabetic pedigrees were selected in this study. Complete laboratory data, including blood pressure, lipid profile and plasma glucose, were collected. The prevalence rates of MS and obesity of four definitions, as defined by National Cholesterol Education Program Adult Treatment Panel Ⅲ (ATPⅢ) in 2005, International Diabetes Federation (IDF) in 2005,Chinese Diabetes Society (CDS) in 2004 aml Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults (JCDCG) in 2007,were analyzed. Results (1)The prevalence rates of MS were 45.40% ,38.74% ,25.08% and 39.29% aecording to four definitions respectively. The prevalence rates of MS were higher in females than in males by using ATPⅢ and IDF definitions (both P<0. 01). (2)The common comhinations of metabolic abnormality was dyslipidemia, hypertension, obesity and hyperglycemia by using four definitions,except in females by using CDS definition. (3)The prevalence rates of obesity were 58.18% ,58.18% ,33.90% and 42.96% acconling to the four definitions respectively. The prevalence rates of MS in obese subjects were 66.59% ,66.59% ,54.85% and 68.99% according to four definitions respectively. (4) Applying the cutoff point for abdominal obesity according to ATPⅢ, IDF and JCDCG definitions, the prevalence rates of abdominal obesity in subjects with body mass index (BMI) <25 kg/m2 were respectively 28.58% and 16.78%, being higher in females than in males(38.90% vs 15.02% ,21.01% vs 11.22% ,both P<0. 01). Conclusion (1)There is significant familial aggregation of MS and obesity,and the first-degree relatives of type 2 diabetic patients are high risk populations. (2) Waist circumference rather than BMI taken as a discriminating component of obesity in MS seems to be clinically more helpful to the early identification and prevention of MS.